FDA’s latest draft guidance emphasizes the agency’s desire for uniform definitions of “protocol deviations” and “important protocol deviations,” and adopts the definitions from ICH E3 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback